BioPharm International
CONTINUE TO SITE >

OR WAIT 15 SECS

John H. Boyd

Articles

By the Numbers: What it Costs to Operate a Biopharmaceutical Facility

Operating costs are the white-hot issue in the boardrooms of our life sciences clients and they tend to rule the site selection process. A soft economy, worldwide trade competition, drug cost containment pressures from the US government, and a lean and mean message sent by the venture capital community mean that quantitative factors that focus on the cost of doing business are trumping qualitative lifestyle factors, especially when evaluating sites for a new biopharmaceutical facility.